Invisible barriers to clinical trials: The impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials

David M. Dilts, Alan B. Sandler

Research output: Contribution to journal › Article › peer-review

134 Scopus citations

Fingerprint

Dive into the research topics of 'Invisible barriers to clinical trials: The impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences